Correlation Between Achillion Pharmaceuticals and Puma Biotechnology
Can any of the company-specific risk be diversified away by investing in both Achillion Pharmaceuticals and Puma Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Achillion Pharmaceuticals and Puma Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Achillion Pharmaceuticals and Puma Biotechnology, you can compare the effects of market volatilities on Achillion Pharmaceuticals and Puma Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Achillion Pharmaceuticals with a short position of Puma Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Achillion Pharmaceuticals and Puma Biotechnology.
Diversification Opportunities for Achillion Pharmaceuticals and Puma Biotechnology
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Achillion and Puma is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Achillion Pharmaceuticals and Puma Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Puma Biotechnology and Achillion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Achillion Pharmaceuticals are associated (or correlated) with Puma Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Puma Biotechnology has no effect on the direction of Achillion Pharmaceuticals i.e., Achillion Pharmaceuticals and Puma Biotechnology go up and down completely randomly.
Pair Corralation between Achillion Pharmaceuticals and Puma Biotechnology
If you would invest 250.00 in Puma Biotechnology on December 2, 2024 and sell it today you would earn a total of 108.00 from holding Puma Biotechnology or generate 43.2% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Achillion Pharmaceuticals vs. Puma Biotechnology
Performance |
Timeline |
Achillion Pharmaceuticals |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Puma Biotechnology |
Achillion Pharmaceuticals and Puma Biotechnology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Achillion Pharmaceuticals and Puma Biotechnology
The main advantage of trading using opposite Achillion Pharmaceuticals and Puma Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Achillion Pharmaceuticals position performs unexpectedly, Puma Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Puma Biotechnology will offset losses from the drop in Puma Biotechnology's long position.Achillion Pharmaceuticals vs. Jeld Wen Holding | Achillion Pharmaceuticals vs. Western Digital | Achillion Pharmaceuticals vs. Lithium Americas Corp | Achillion Pharmaceuticals vs. BCE Inc |
Puma Biotechnology vs. Ultragenyx | Puma Biotechnology vs. Crinetics Pharmaceuticals | Puma Biotechnology vs. Arvinas | Puma Biotechnology vs. Revolution Medicines |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |